The link between abdominal obesity, metabolic syndrome and cardiovascular disease.

By S. Ritchie, J. Connell. NMCD. Nutrition Metabolism and Cardiovascular Diseases, 2007

736 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Epidemiology

View Paper: https://www.semanticscholar.org/paper/17cd672b5e75f2dc47a6119541cb58e04ed35380

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Jaspinder Kaur

In Endocrinology, Diabetes and Metabolism

1. Jaspinder Kaur
2. I. Graham

In Epidemiology

1. Julian P. T. Higgins
2. Jaspinder Kaur
3. I. Graham

Citations in the corpus

• The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. (2012, background): “Visceral obesity itself is an independent component of metabolic syndrome and the magnitude of obesity directly relates to the prognosis of this condition [7, 13, 14].”
• Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review (2008, background): “There are moderate associations of IL-6 levels with some established risk factors (notably smoking, diabetes, and dyslipidemia) and with several downstream inflammatory markers, consistent with the key role of IL-6 in mediating inflammatory cascades [3–5,41–44].”
• A Comprehensive Review on Metabolic Syndrome (2014, methodology): “In contrast, the ATPIII definitions were developed which use measurements and laboratory results that are readily available to physicians, facilitating their clinical and epidemiological application and therefore have remained a backbone for subsequent classifications such as the IDF diagnostic crit”